Software Quality Assurance

By:   Claude Y. Laporte, Alain April (Université du Québec), Susan Arena, Leo R. Best
Imprint:   John Wiley & Sons Inc
Country of Publication:   United States
Edition:   11th Revised edition
Dimensions:   Height: 231mm,  Width: 155mm,  Spine: 41mm
Weight:   1.134kg
ISBN:   9781118501825
ISBN 10:   1118501829
Pages:   624
Publication Date:   15 December 2017
Audience:   College/higher education ,  A / AS level
Format:   Hardback
Publisher's Status:   Active

Claude Y. Laporte, PhD, has coordinated the development, implementation, and deployment of systems and software engineering processes and project management processes, and has trained software engineers in America, Europe, and Asia. Since 2000, he has been a professor at the École de technologie supérieure (ÉTS), a Canadian engineering school, where he teaches software engineering. In 2013, Professor Laporte was awarded an honorary doctorate for his contributions to software engineering. He is the Project Editor of the set of ISO/IEC 29110 systems and software engineering life cycle standards and guides developed specifically for Very Small Entities (VSEs). He has also written two French software engineering textbooks with Dr. April. Dr. Laporte is a co-author of another book targeted at managers of small systems engineering organizations. Alain April, PhD, is a full professor of software engineering and IT at ÉTS University, Québec, Canada. He specializes in software quality assurance and IT process mapping/conformity in the industry transfer of Big Data HPC applications based on Spark, H2O.ai, and other cloud computing technologies applied to healthcare, construction, banking, and financial industries. Professor April has been developing healthcare HPC applications in the area of genomic visualization, genotyping sequencing, and whole genome sequencing, extending Berkeley's Adam data structure for HPC. These applied research projects deploy large-scale machine learning algorithms in research hospitals for specific use cases, such as type 2 diabetes early prediction and leukemia treatments in children.